NKTR
Nektar Therapeutics
40.80$
+1.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -84.1% | 30.6% | -88.2% | -37.1% | -69.2% | -65.5% | -79.1% | -71.7% | -68.4% | -61.8% | -42.6% | 53.6% | -161.6% | 55.2% | -35.1% | -159.1% | -159.8% | -25.9% | -70.8% | -31.7% | -70.7% | -26.1% | 60.2% | -286.8% | -204.9% | -404.9% | -330.2% | -213.7% | -178.5% | -377.5% | |
| 17.4% | 15.0% | 16.5% | 17.5% | 19.6% | 52.1% | 20.0% | 17.3% | 16.8% | 20.8% | 15.0% | 10.3% | 24.9% | 20.7% | 10.4% | 20.9% | 17.9% | 9.6% | 6.4% | 5.6% | 9.3% | 4.8% | 0.9% | 11.5% | 9.3% | 13.9% | 14.2% | 8.7% | 4.5% | -8.1% | |
| – | – | – | – | 1.7% | 1.1% | 0.6% | 0.2% | 1.0% | 1.5% | 0.0% | 5.4% | 10.9% | 14.4% | 10.9% | 26.4% | 20.0% | 11.9% | 8.5% | 8.5% | 15.6% | 11.9% | 7.4% | 87.1% | 61.6% | 92.9% | 62.3% | 37.0% | 22.0% | 22.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 28.3% | 32.0% | 12.5% | 7.7% | 7.6% | 8.0% | 7.8% | 6.4% | 77.2% | 49.7% | 117.9% | 55.0% | – | – | – | |
| 40.6% | 73.4% | -21.8% | 12.5% | 7.0% | 10.4% | 11.0% | -17.6% | -6.7% | 3.6% | -4.1% | 39.1% | -29.7% | 163.6% | -40.7% | -20.9% | 2.0% | 60.8% | -58.0% | -15.0% | 4.8% | -12.2% | -3.3% | 18.9% | 10.9% | -22.6% | 0.5% | -22.0% | -6.3% | -67.0% | |
| 31.9% | 106.2% | 158.7% | 49.6% | 104.3% | 44.3% | 17.2% | 17.6% | 23.8% | 14.2% | 10.3% | 12.0% | 20.9% | 28.8% | 19.8% | 13.6% | 13.0% | 2.7% | 5.0% | 4.9% | 3.9% | 3.1% | 1.2% | 22.9% | 4.7% | 14.7% | 6.2% | 1.0% | 1.5% | 0.3% | |
| -55.1% | -521.3% | -29.8% | -199.3% | -580.6% | -99.4% | 42.5% | 3.8% | -77.8% | 25.7% | -53.7% | -12.0% | 304.5% | -207.2% | 10.5% | -156.6% | 139.2% | 33.5% | -18.7% | -6.2% | -49.8% | -9.4% | -115.6% | 180.5% | 324.5% | 199.0% | 397.4% | 154.9% | 144.8% | -2.2% | |
| – | – | – | – | – | – | – | – | 5.9% | 1.0% | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 1.1% | 1.0% | – | – | – | – | – | 313.8% | 5.1% | 5.5% | 81.5% | 14.0% | 126.7% | 19.3% | 71.4% | 20.4% | 15.3% | 32.6% | – | 0.0% | -3.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.8% | -119.4% | -2.0% | -1.8% | 42.7% | -3.6% | -1.7% | -20.9% | -218.1% | -163.5% | 0.0% | 0.0% | – | – | – | |
| 353.6% | 468.4% | 167.6% | 257.0% | 848.5% | 29.2% | 40.8% | 95.3% | 181.5% | 217.7% | 5.4% | -37.3% | -55.2% | 4.9% | 4.7% | 311.0% | 33.0% | 1.5% | 76.2% | 56.7% | 123.1% | 17.7% | 71.4% | 20.4% | -52.5% | 35.6% | 1.6% | 0.0% | 42.8% | 326.9% | |
| 214.5% | -22.3% | 49.6% | 20.6% | 198.7% | -135.8% | 4.3% | 27.5% | 35.3% | 181.5% | -90.7% | 4.6% | 87.9% | -147.3% | -20.0% | -3.4% | 12.5% | 9.2% | -13.3% | 18.7% | 2.5% | -17.8% | 15.9% | -86.0% | 67.1% | -170.5% | 68.4% | -58.8% | 9.1% | -52.8% | |
| -115.9% | -75.6% | -246.9% | -86.6% | -173.5% | -109.8% | -96.3% | -89.4% | -92.2% | -76.0% | -52.9% | 41.6% | -182.6% | 26.5% | -54.9% | -172.7% | -172.9% | -28.6% | -75.7% | -36.5% | -74.6% | -29.3% | 59.0% | -309.7% | -209.6% | -419.6% | -336.4% | -214.7% | -180.0% | -377.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.